TrialHuman vaccines & immunotherapeutics2018

Immunogenicity and safety of a novel seasonal influenza preservative-free vaccine manufactured in Kazakhstan: Results of a randomized, comparative, phase II clinical trial in adults.

Gulbanu Sarsenbayeva et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.